Cargando…

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis

Currently, there is still no effective curative treatment for the development of late-stage liver fibrosis. Here, we have illustrated that TB001, a dual glucagon-like peptide-1 receptor/glucagon receptor (GLP-1R/GCGR) agonist with higher affinity towards GCGR, could retard the progression of liver f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Nazi, Xu, Hongjiao, Liu, Jiahua, Zhao, Qian, Chen, Hui, Yan, Zhibin, Yang, Runling, Luo, Zhiteng, Liu, Qi, Ouyang, Jianmei, Wu, Shuohan, Luo, Suijia, Ye, Shuyin, Lin, Runfeng, Sun, Xi, Xie, Junqiu, Lan, Tian, Wu, Zhongdao, Wang, Rui, Jiang, Xianxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136578/ https://www.ncbi.nlm.nih.gov/pubmed/35646543 http://dx.doi.org/10.1016/j.apsb.2021.12.016

Ejemplares similares

Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs–EBP interaction recover NAFLD through enhancing mitochondrial function in mice
por: Song, Nazi, et al.
Publicado: (2023)

AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
por: Xu, Hongjiao, et al.
Publicado: (2020)

Author Correction: AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
por: Xu, Hongjiao, et al.
Publicado: (2021)

Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023)

Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery
por: Mizera, Mikołaj, et al.
Publicado: (2021)

Selective polypeptide ligand binding to the extracellular surface of the transmembrane domains of the class B GPCRs GLP-1R and GCGR
por: Wang, Huixia, et al.
Publicado: (2023)

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
por: Pickford, Phil, et al.
Publicado: (2021)

Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
por: Boland, Michelle L., et al.
Publicado: (2020)

BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
por: Zimmermann, Tina, et al.
Publicado: (2022)

The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis
por: Yan, Zhibin, et al.
Publicado: (2021)

Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
por: Zhang, Yulin, et al.
Publicado: (2021)

GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr(−/−) mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
por: Patel, Anita, et al.
Publicado: (2018)

High glucose-induced glucagon resistance and membrane distribution of GCGR revealed by super-resolution imaging
por: Gao, Jing, et al.
Publicado: (2023)

Site-specific labeling of an anti-MUC1 antibody: probing the effects of conjugation and linker chemistry on the internalization process
por: Xu, Hongjiao, et al.
Publicado: (2019)

Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
por: Wang, Qinghua, et al.
Publicado: (2010)

Glucagon Promotes Gluconeogenesis through the GCGR/PKA/CREB/PGC-1α Pathway in Hepatocytes of the Japanese Flounder Paralichthys olivaceus
por: Yang, Mengxi, et al.
Publicado: (2023)

The first pediatric case of glucagon receptor defect due to biallelic mutations in GCGR is identified by newborn screening of elevated arginine
por: Li, Hong, et al.
Publicado: (2018)

Potent and Persistent Antibody Response in COVID-19 Recovered Patients
por: Tian, Xiaodong, et al.
Publicado: (2021)

Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-Fc
por: Yang, Yi, et al.
Publicado: (2016)

Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
por: Yang, Jianxin, et al.
Publicado: (2011)

Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells
por: Godfrey, Jason, et al.
Publicado: (2022)

Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver–α-cell axis
por: Liu, Qiaofeng, et al.
Publicado: (2021)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

A Potent α/β-Peptide Analogue of GLP-1 with Prolonged Action in Vivo
por: Johnson, Lisa M., et al.
Publicado: (2014)

Case report: A rare case of urinary myiasis induced by the fourth instar larvae of Telmatoscopus albipunctatus
por: Zhang, Beibei, et al.
Publicado: (2017)

β-Actin: Not a Suitable Internal Control of Hepatic Fibrosis Caused by Schistosoma japonicum
por: Zhang, Beibei, et al.
Publicado: (2019)

Corrigendum: Potential gut microbiota features for non-invasive detection of schistosomiasis
por: Lin, Datao, et al.
Publicado: (2022)

Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis
por: Lin, Datao, et al.
Publicado: (2022)

Anti-cancer small molecule JP-8g exhibits potent in vivo anti-inflammatory activity
por: Sun, Yulong, et al.
Publicado: (2014)

Reversal of liver fibrosis after splenectomy in a patient with advanced schistosomiasis japonica: A case report with 4-year follow-up
por: Song, Langui, et al.
Publicado: (2019)

GLP-1 Receptor: A New Target for Sepsis
por: Yang, Fuxun, et al.
Publicado: (2021)

Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
por: Zhang, Hongkai, et al.
Publicado: (2015)

Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects
por: Zhong, Xia, et al.
Publicado: (2019)

One-Step Synthesis of Chiral Oxindole-type Analogues with Potent Anti-inflammatory and Analgesic Activities
por: Sun, Yulong, et al.
Publicado: (2015)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
por: Yang, Li, et al.
Publicado: (2021)

Gut Microbiota Modulates Intestinal Pathological Injury in Schistosoma japonicum-Infected Mice
por: Zhang, Beibei, et al.
Publicado: (2020)

Hepatic progenitor cells promote the repair of schistosomiasis liver injury by inhibiting IL-33 secretion in mice
por: Zhang, Beibei, et al.
Publicado: (2021)

Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
por: Cao, Zhiliang, et al.
Publicado: (2010)

Functional GLP-1R antibodies identified from a synthetic GPCR-focused library demonstrate potent blood glucose control
por: Liu, Qiang, et al.
Publicado: (2021)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j4kt6uqjc7lbngbn7tgd5bisll